{"id":15710,"date":"2022-10-27T11:14:00","date_gmt":"2022-10-27T18:14:00","guid":{"rendered":"https:\/\/www.ispot.tv\/hub\/?post_type=free_reports&#038;p=15710"},"modified":"2024-08-23T11:02:46","modified_gmt":"2024-08-23T18:02:46","slug":"q3-pharma-tv-advertising-rundown","status":"publish","type":"free_reports","link":"https:\/\/www.ispot.tv\/hub\/resources\/free-reports\/q3-pharma-tv-advertising-rundown\/","title":{"rendered":"Q3 Pharma TV Advertising Rundown"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\" style=\"font-size:18px\">During new-airing programming, pharmaceutical est. national TV ad spend and TV ad impressions have decreased over the course of 2022 \u2013 but are running closely to figures from 2021. In Q3, RINVOQ was the most-seen brand across its various use cases, though it\u2019s far from the only prevalent brand as focus shifts to cable news and the coming election cycle.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" style=\"font-size:18px\">Download iSpot\u2019s Q3 pharmaceutical TV ad report today to dive into more on brand and creative performance from last quarter, along with more insights on emerging advertisers, top networks and programs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>During new-airing programming, pharmaceutical est. national TV ad spend and TV ad impressions have decreased over the course of 2022 \u2013 but are running closely to figures from 2021. In Q3, RINVOQ was the most-seen brand across its various use cases, though it\u2019s far from the only prevalent brand as focus shifts to cable news&#8230; Read More<\/p>\n","protected":false},"author":50,"featured_media":15750,"menu_order":0,"template":"resources-custom.php","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"ispot_product_categories":[],"class_list":["post-15710","free_reports","type-free_reports","status-publish","has-post-thumbnail","hentry"],"acf":{"expiration_date":""},"_links":{"self":[{"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/free_reports\/15710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/free_reports"}],"about":[{"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/types\/free_reports"}],"author":[{"embeddable":true,"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/users\/50"}],"version-history":[{"count":18,"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/free_reports\/15710\/revisions"}],"predecessor-version":[{"id":23251,"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/free_reports\/15710\/revisions\/23251"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/media\/15750"}],"wp:attachment":[{"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/media?parent=15710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/categories?post=15710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/tags?post=15710"},{"taxonomy":"ispot_product_categories","embeddable":true,"href":"https:\/\/www.ispot.tv\/hub\/wp-json\/wp\/v2\/ispot_product_categories?post=15710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}